IN2012DN04875A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN04875A IN2012DN04875A IN4875DEN2012A IN2012DN04875A IN 2012DN04875 A IN2012DN04875 A IN 2012DN04875A IN 4875DEN2012 A IN4875DEN2012 A IN 4875DEN2012A IN 2012DN04875 A IN2012DN04875 A IN 2012DN04875A
- Authority
- IN
- India
- Prior art keywords
- antigen
- stimulated
- immune response
- prx1
- compositions
- Prior art date
Links
- 239000000427 antigen Substances 0.000 abstract 5
- 102000036639 antigens Human genes 0.000 abstract 5
- 108091007433 antigens Proteins 0.000 abstract 5
- 230000028993 immune response Effects 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- 239000002671 adjuvant Substances 0.000 abstract 1
- 230000004853 protein function Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/17—Monocytes; Macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
- C12Y111/01—Peroxidases (1.11.1)
- C12Y111/01015—Peroxiredoxin (1.11.1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26764709P | 2009-12-08 | 2009-12-08 | |
| PCT/US2010/059411 WO2011071988A1 (en) | 2009-12-08 | 2010-12-08 | Methods and compositions using peroxiredoxin 1 (prx1) as an adjuvant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN04875A true IN2012DN04875A (https=) | 2015-09-25 |
Family
ID=44145890
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4875DEN2012 IN2012DN04875A (https=) | 2009-12-08 | 2010-12-08 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9050291B2 (https=) |
| EP (1) | EP2509623B1 (https=) |
| KR (1) | KR20130028044A (https=) |
| CN (1) | CN102834110B (https=) |
| CA (1) | CA2782132A1 (https=) |
| IN (1) | IN2012DN04875A (https=) |
| WO (1) | WO2011071988A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103468652A (zh) * | 2013-07-15 | 2013-12-25 | 中国科学院海洋研究所 | 一种纯化fitc标记的虾白斑综合症病毒（wssv）的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9612214D0 (en) * | 1996-06-11 | 1996-08-14 | Mallinckrodt Veterinary Inc | Vaccine |
| DE69841982D1 (de) * | 1997-03-14 | 2010-12-16 | Philadelphia Children Hospital | Zusammensetzungen zum einsatz in einer gentherapie zur behandlung von hämophilie |
| IL125608A0 (en) * | 1998-07-30 | 1999-03-12 | Yeda Res & Dev | Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| US6753314B1 (en) * | 1999-04-01 | 2004-06-22 | Curagen Corporation | Protein-protein complexes and methods of using same |
| US20020168353A1 (en) * | 2001-03-23 | 2002-11-14 | Lynn Ralf Geiben | Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof |
| US20090291087A1 (en) | 2002-03-21 | 2009-11-26 | University Of Florida Research Foundation, Inc. | Modulating angiogenesis |
| US20030199464A1 (en) | 2002-04-23 | 2003-10-23 | Silviu Itescu | Regeneration of endogenous myocardial tissue by induction of neovascularization |
| US8153410B2 (en) * | 2003-07-07 | 2012-04-10 | Fox Chase Cancer Center | Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules |
| AU2007211334A1 (en) | 2006-02-01 | 2007-08-09 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
| US8236320B2 (en) * | 2007-11-02 | 2012-08-07 | Health Research Inc. | Compositions and methods for using CA9 protein to stimulate an immune response |
-
2010
- 2010-12-08 KR KR1020127016307A patent/KR20130028044A/ko not_active Withdrawn
- 2010-12-08 CA CA2782132A patent/CA2782132A1/en not_active Abandoned
- 2010-12-08 US US12/963,008 patent/US9050291B2/en not_active Expired - Fee Related
- 2010-12-08 IN IN4875DEN2012 patent/IN2012DN04875A/en unknown
- 2010-12-08 WO PCT/US2010/059411 patent/WO2011071988A1/en not_active Ceased
- 2010-12-08 CN CN201080060971.5A patent/CN102834110B/zh not_active Expired - Fee Related
- 2010-12-08 EP EP10836594.1A patent/EP2509623B1/en not_active Not-in-force
Also Published As
| Publication number | Publication date |
|---|---|
| EP2509623B1 (en) | 2015-03-25 |
| CN102834110B (zh) | 2015-01-14 |
| KR20130028044A (ko) | 2013-03-18 |
| EP2509623A1 (en) | 2012-10-17 |
| WO2011071988A1 (en) | 2011-06-16 |
| US20110177129A1 (en) | 2011-07-21 |
| CN102834110A (zh) | 2012-12-19 |
| US9050291B2 (en) | 2015-06-09 |
| CA2782132A1 (en) | 2011-06-16 |
| EP2509623A4 (en) | 2013-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2013054199A3 (en) | Cmv antigens and uses thereof | |
| WO2008116078A3 (en) | Stimulation of an immune response by cationic lipids | |
| SMT201700182T1 (it) | Composizioni di composti modificanti la risposta immunitaria lipidati, formulazioni e metodi | |
| PT2640842T (pt) | Métodos e composições para induzir uma resposta imune a egfrviii | |
| ZA201307394B (en) | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses | |
| EA201391597A1 (ru) | Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки | |
| EA201490381A1 (ru) | Синтетические наноносители, которые стимулируют формирование гуморального иммунного ответа и иммунного ответа, опосредованного цитотоксическими т-лимфоцитами (ctl) | |
| PH12014501836A1 (en) | Novel adjuvant compositions | |
| WO2012125551A8 (en) | Listeria-based adjuvants | |
| AU2015296298A8 (en) | Flagellin-based agents and uses including effective vaccination | |
| MX2012014904A (es) | Metodos de tratamiento utilizando inhibidores de tlr7 y/o tlr9. | |
| WO2009026574A3 (en) | Immunogenic compositions and uses thereof | |
| PH12013500933A1 (en) | Methods and compositions for neural disease immunotherapy | |
| WO2012109238A3 (en) | Methods for increasing immune responses using agents that directly bind to and activate ire-1 | |
| WO2009134429A3 (en) | Methods and compositions for modulating immunological tolerance | |
| PH12013500616A1 (en) | Antibody compositions and methods of use | |
| SG10201900041VA (en) | Meningococcus vaccines | |
| WO2013188627A3 (en) | Cationic lipid vaccine compositions and methods of use | |
| ZA201003964B (en) | Compositions for and methods of enhancing the immune response to antigens | |
| IN2014CN03454A (https=) | ||
| EP3908315A4 (en) | COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSE TO VACCINATION AND ENHANCING VACCINE PRODUCTION | |
| WO2012075104A3 (en) | Novel non-primate hepacivirus | |
| IN2012DN04875A (https=) | ||
| MX2012002829A (es) | Producción de una respuesta inmune para disminuir el riesgo de contagio por brucelosis. | |
| EA201200538A1 (ru) | Арабиногалактан для повышения приобретенного иммунного ответа |